Fig 4.

B220⁺ mouse B cells from total splenocyte and isolated B cell cultures infected in vitro with rRABV upregulate surface expression of the antigen presentation molecule MHC-II. Total mouse splenocytes and isolated splenic B cells, cultured and infected as described in the legend to Fig. 1, were stained for surface B220 and MHC-II, as well as intracellular RABV-N, for analysis by flow cytometry. Data are from the experiments and number of replicates per treatment described in the legend to Fig. 3. (A) Representative gating strategy of cells, as described in the legend to Fig. 3A, gated on surface MHC-II and intracellular RABV-N staining. (B and C) Number of live RABV-N⁺ MHC-II^hi B220⁺ B cells normalized to the number of live cells from total splenocyte cultures (B) or live B220⁺ cells from isolated B cell cultures (C) that were mock infected or infected in vitro with either rRABV or rRABV-UV at the indicated time points. (D) Representative histogram showing staining intensity of surface MHC-II expression in live B220⁺ B cells from total splenocyte cultures either mock infected or infected in vitro with either rRABV or rRABV-UV. (E and F) MFI of MHC-II staining on live RABV-N⁺ B220⁺ B cells from total splenocyte cultures (E) or isolated B cell cultures (F) infected with either rRABV (black bars) or rRABV-UV (gray bars), normalized to the MHC-II MFI of B220⁺ B cells from corresponding mock-infected cultures. To compare two groups of data, we used an unpaired, two-tailed Student's t test (***, P < 0.001).